Category: News
New Alzheimer’s prevention trial in young people (Links to an external site)
$11.5 million commitment supports new Alzheimer’s prevention clinical trial (Links to an external site)
New eligibility criteria for participation in Tau NexGen E2814: A requirement for participants to learn their genetic status prior to enrollment
The new Tau NexGen E2814 clinical trial planned for DIAN-TU will be launching at most sites in 2022. This new trial design will offer individuals who have a dominantly inherited Alzheimer’s disease (DIAD) mutation access to investigational drugs that target both amyloid and tau. All participants will receive the anti-amyloid drug and also be randomized […]
International Alzheimer’s clinical trial to test two drugs in combination (Links to an external site)
Global Incubator Seed Grants awarded (Links to an external site)
The Search for a Drug to End Alzheimer’s (Links to an external site)
Some antiamyloids remove target plaques from the brain, yet don’t seem to halt cognitive decline. Researchers are working to understand why.
Aiming at the Tangle’s Heart? DIAN-TU Trial to Torpedo Tau’s Core (Links to an external site)
Encouraging findings in Alzheimer’s prevention trial lead to the next phase (Links to an external site)
International Alzheimer’s clinical trial to test tau drugs (Links to an external site)
